Veno-arterial ECMO is a powerful tool for resuscitating patients in refractory cardiogenic shock. However, outcomes are poor unless it is implemented correctly and converted to more long term devices in a stepwise and timely fashion. In this article we detail the steps required to guarantee the highest survival rate for these critically ill patients
Evolution of extracorporeal life support (ECLS) technology has added a new dimension to the intensiv...
As extracorporeal membrane oxygenation increases the left ventricular afterload, a successful treatm...
ObjectivesCardiogenic shock refractory to conventional therapy has very high mortality and limited t...
Veno-arterial ECMO is a powerful tool for resuscitating patients in refractory cardiogenic shock. Ho...
Veno-arterial extracorporeal membrane oxygenation is used in patients requiring biventricular suppor...
Extra corporeal membrane oxygenation (ECMO) is a life-saving technique to manage refractory cardiopu...
International audiencePURPOSE OF REVIEW: Temporary circulatory support (TCS) with venoarterial extra...
Each cannulation strategy for venoarterial extracorporeal membrane oxygenation (VA ECMO) has distinc...
Extracorporeal membrane oxygenation (ECMO) for cardiac failure is on the rise worldwide. Some challe...
Cardiogenic shock accounts for ~100,000 annual hospital admissions in the United States. Despite imp...
Cardiogenic shock (CS) still carries an unacceptably high mortality (30–60%), despite several therap...
International audienceThe objective of the study is to describe an emergency procedure for left vent...
In the United States, ~100,000 patients are hospitalized annually for cardiogenic shock with 27–51% ...
Since the first clinical use of extracorporeal circulation in the last century [1] by John Gibbon an...
Veno-venous (VV) and veno-arterial (VA) extracorporeal membrane oxygenation (ECMO) therapy is widely...
Evolution of extracorporeal life support (ECLS) technology has added a new dimension to the intensiv...
As extracorporeal membrane oxygenation increases the left ventricular afterload, a successful treatm...
ObjectivesCardiogenic shock refractory to conventional therapy has very high mortality and limited t...
Veno-arterial ECMO is a powerful tool for resuscitating patients in refractory cardiogenic shock. Ho...
Veno-arterial extracorporeal membrane oxygenation is used in patients requiring biventricular suppor...
Extra corporeal membrane oxygenation (ECMO) is a life-saving technique to manage refractory cardiopu...
International audiencePURPOSE OF REVIEW: Temporary circulatory support (TCS) with venoarterial extra...
Each cannulation strategy for venoarterial extracorporeal membrane oxygenation (VA ECMO) has distinc...
Extracorporeal membrane oxygenation (ECMO) for cardiac failure is on the rise worldwide. Some challe...
Cardiogenic shock accounts for ~100,000 annual hospital admissions in the United States. Despite imp...
Cardiogenic shock (CS) still carries an unacceptably high mortality (30–60%), despite several therap...
International audienceThe objective of the study is to describe an emergency procedure for left vent...
In the United States, ~100,000 patients are hospitalized annually for cardiogenic shock with 27–51% ...
Since the first clinical use of extracorporeal circulation in the last century [1] by John Gibbon an...
Veno-venous (VV) and veno-arterial (VA) extracorporeal membrane oxygenation (ECMO) therapy is widely...
Evolution of extracorporeal life support (ECLS) technology has added a new dimension to the intensiv...
As extracorporeal membrane oxygenation increases the left ventricular afterload, a successful treatm...
ObjectivesCardiogenic shock refractory to conventional therapy has very high mortality and limited t...